A Phase II Study of Radiation Therapy, Paclitaxel Poliglumex, and Carboplatin in Stage III Non-Small Cell Lung Cancer
Status:
Terminated
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
This study is intended to evaluate the role of paclitaxel poliglumex and carboplatin in the
treatment of unresectable Stage III non-small cell lung cancer along with radiation therapy
in a multi-institutional trial. Consolidation chemotherapy with paclitaxel poliglumex and
carboplatin will follow the completion of chemoradiation.